Dr.Datsons Labs (Delisted) share news and announcements

BSE: 533412

Formerly Aanjaneya Lifecare

Last traded ₹6.40 on 21 May 2015

Delisted on 14 Feb 2020.

Dr.Datsons Labs share news and announcements

899 announcements, routine notices left out, newest first. Page 6 of 18.

Apr 2014
- 5 Apr · Management
  Dr.Datsons Labs Ltd has informed BSE that Mr. Chandulal Champaklal Shah, Chairman Emeritus of the Company, has tendered his resignation from the Chairman Emeritus of the Company with effect ....
- 4 Apr · Disclosure
  Finaventure Capital Ltd has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 3 Apr · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
Mar 2014
- 28 Mar · Disclosure
  Vide letter dated March 26, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of Disclosure under Regulation 13(1) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992. (opens in a new tab)
- 27 Mar · Disclosure
  Kuvera Fund Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 18 Mar · Board meeting
  Dr. Datson's Labs Limited has informed the Exchange regarding the Outcome of the meeting of the Board of Directors of the Company held on March 18, 2014. (opens in a new tab)
- 18 Mar · Board meeting
  Dr.Datsons Labs Ltd has informed BSE about Outcome of Board Meeting held on March 18, 2014. (opens in a new tab)
- 18 Mar · Board meeting
  Due to non-availability of requisite quorum the scheduled meeting of the Board of Directors of the Company to be held on March 15, 2014 is decided to reschedule the same on March 18, 2014. (opens in a new tab)
  Not held on this date
- 18 Mar · Board meeting Rescheduled
  Dr. Datson's Labs Limited has informed the Exchange that due to non-availability of requisite quorum the scheduled Meeting of the Board of Directors of the Company to be held on March 15, 2014, could not be held and it is decided to the said board meeting to be held the day and date of which will be to the exchange separately. (opens in a new tab)
- 18 Mar · Reschedule of Board Meeting on March 18, 2014
  Dr.Datsons Labs Ltd has informed BSE that due to non-availability of requisite quorum the scheduled Meeting of the Board of Directors of the Company to be held March 15, 2014, for which .... (opens in a new tab)
- 18 Mar · Board meeting
  Dr.Datsons Labs Ltd has informed BSE that due to non-availability of requisite quorum the scheduled Meeting of the Board of Directors of the Company to be held on March 15, 2014, for which ....
- 12 Mar · Board meeting
  To consider issue and allotment of equity shares Pursuant to FCCBs conversion notice(s) received from The Bondholders of the company and any other matter with the permission of the Chair. (opens in a new tab)
- 12 Mar · Board Meeting on March 15, 2014
  Dr.Datsons Labs Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on March 15, 2014, inter alia, to consider issue and allotment of equity shares ....
- 5 Mar · Disclosure
  Finaventure Capital Ltd has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 5 Mar · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
Feb 2014
- 25 Feb · Management
  Dr. Datson's Labs Limited has informed the Exchange that Dr. Ullooppee Badade and Mr. Balkrishna Parab, Directors of the Company, has tendered their resignation from the Directorship of the company with effect from February 24, 2014.Further, Mr. Prabhat Kumar Goyal, Executive-Whole time Director of the company vacated the post as the Executive Director but will continue as an Non Executive Non Independent Director of the company with effect from February 24, 2014.
- 25 Feb · Update on Directorship of the Company
  Dr.Datsons Labs Ltd has informed BSE that Dr. Ullooppee Badade and Mr. Balkrishna Parab, Directors of the Company, has tendered their resignation from the Directorship of the Company with ....
- 14 Feb · Results
  Dr.Datsons Labs Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013. (opens in a new tab)
- 14 Feb · Results
  Dr. Datson's Labs Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2013. (opens in a new tab)
- 7 Feb · Disclosure
  Dr.Datsons Labs Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 6 Feb · Disclosure
  Finaventure Capital Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 4 Feb · Disclosure
  Dr. Datson's Labs Limited has submitted to the Exchange, vide letter dated February 04, 2014 a copy of Disclosures under Regulation 13(4), 13(4A) and 13(6) of Prohibition of Insider Trading Regulation, 1992. (opens in a new tab)
- 4 Feb · Disclosure
  Finaventure Capital Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 4 Feb · Disclosure
  Finaventure Capital Ltd has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
Jan 2014
Nov 2013
- 12 Nov · Results
  Dr.Datsons Labs Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013. (opens in a new tab)
- 12 Nov · Results
  Dr. Datson's Labs Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013. (opens in a new tab)
Oct 2013
- 29 Oct · Board meeting
  To take on record the Unaudited (Provisional) Financial Results for the Second Quarter ended September 30, 2013. Any other matter with the permission of the Chair.
Sep 2013
- 30 Sep · Meeting
  Dr. Datson's Labs Limited has informed the Exchange regarding the outcome of the Annual General Meeting of the Company held on September 30, 2013. (opens in a new tab)
- 30 Sep · Meeting
  Dr.Datsons Labs Ltd has informed BSE that the 7th Annual General Meeting (AGM) of the Company was held on September 30, 2013. (opens in a new tab)